Replies to post #32528 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

Agreed, Gantor (and Equal). Especially if they license both EU and U.S. Axal rights, with potential EU approval looming, I would expect a significant amount of upfront cash. James seems to think this is quite possible and I know he has his ear to the ground. And the KITE valuation should only help.